EUVIMEDEUVIMED entdecken
VergleichsstudieValidierungsstudieMultizentrische Studie

Development and validation of a deep learning-based model for predicting prostate cancer in patients with gray-zone PSA levels: a comparative study with clinician observations

Yinzhong Wang, Wenhui Zhao, Ruiping Wang, Meng Qi, Li Zhang, Dali Xi, Miaomiao Wang, Ruifeng Yan, Junqiang Lei

World Journal of Urology · 2025

DOI: 10.1007/s00345-025-06174-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift World Journal of Urology, 2025. Verfasst von Yinzhong Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of radiology, First Hospital of LanZhou University, Lanzhou, 730000, Gansu, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Deep Learning, Prostate-Specific Antigen. Die Arbeit nennt 22 Literaturangaben. Gefördert von: the Health Industry Scientific Research Program of Gansu Province, the Intra-Hospital Fund of the First Hospital of Lanzhou University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to develop and validate a Deep Learning(DL)-based model for detecting Prostate cancer (PCa) in patients with gray-zone PSA levels using multiparametric Magnetic Resonance Imaging (mp-MRI). MATERIALS AND METHODS: This retrospective multi-center study initially reviewed data from 1778 patients with suspected prostate lesions who presented at multiple hospitals between December 2015 and October 2023. The DL algorithm was trained on T2-weighted imaging (T2WI) and apparent diffusion coefficient (ADC) values. The performance of the algorithm was evaluated using the area under the receiver operating characteristic (ROC) curve and compared to the diagnostic performance of radiologists with varying levels of expertise. RESULTS: The final study cohort comprised 274 patients, who were divided into training, validation, and test sets in a 6:2:2 ratio, corresponding to 162, 56, and 56 patients, respectively. The mean age of the patients was 71.8 years, and the cohort included 90 patients with prostate cancer and 184 without. The multi-attribute Convolutional Neural Networks (CNNs) model achieved an area under the curve (AUC) of 0.84, surpassing individual ADC and T2WI models. It also outperformed a transformer-based model (AUC 0.79). When compared to radiologists, the DL model performed similarly to experienced radiologists (AUC 0.86) and outperformed less experienced radiologists (AUC 0.71). CONCLUSIONS: The multimodal CNNs, integrating ADC and T2WI data, demonstrated high accuracy for PCa detection in patients with gray-zone PSA levels, comparable to senior radiologists. This model can aid clinical decision-making, assist in challenging cases, and help reduce unnecessary biopsies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsDeep LearningProstate-Specific AntigenHumansMaleRetrospective StudiesAgedMiddle AgedPredictive Value of TestsMultiparametric Magnetic Resonance Imaging

Stichwörter der Autor:innen

Convolutional neural networksDeep LearningProstate cancer

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of radiology, First Hospital of LanZhou University, Lanzhou, 730000, Gansu, China.
  • Intelligent Imaging Medical Engineering Research Center of Gansu Province, Lanzhou, Gansu, China.
  • Accurate Image Collaborative Innovation International Science and Technology Cooperation Base of Gansu Province, Lanzhou, Gansu, China.
  • Gansu Province clinical research center for radiology imaging , Lanzhou, China.
  • The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
  • No.2 Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Hospital of Traditional Chinese Medicine), Guangzhou, Guangdong, China.

Förderung

  • the Health Industry Scientific Research Program of Gansu Province
  • the Intra-Hospital Fund of the First Hospital of Lanzhou University

Zitieren

APA

Wang, Y., Zhao, W., Wang, R., Qi, M., Zhang, L., Xi, D., Wang, M., Yan, R., & Lei, J. (2025). Development and validation of a deep learning-based model for predicting prostate cancer in patients with gray-zone PSA levels: a comparative study with clinician observations. World Journal of Urology. https://doi.org/10.1007/s00345-025-06174-3

Vancouver

Wang Y, Zhao W, Wang R, Qi M, Zhang L, Xi D, et al. Development and validation of a deep learning-based model for predicting prostate cancer in patients with gray-zone PSA levels: a comparative study with clinician observations. World Journal of Urology. 2025. doi:10.1007/s00345-025-06174-3

BibTeX
@article{Wang2025,
  author = {Wang, Yinzhong and Zhao, Wenhui and Wang, Ruiping and Qi, Meng and Zhang, Li and Xi, Dali and Wang, Miaomiao and Yan, Ruifeng and Lei, Junqiang},
  title = {Development and validation of a deep learning-based model for predicting prostate cancer in patients with gray-zone PSA levels: a comparative study with clinician observations},
  journal = {World Journal of Urology},
  year = {2025},
  doi = {10.1007/s00345-025-06174-3}
}
Kostenlos starten →